Effectiveness of Manuel Therapy Methods in Pes Planus

NCT ID: NCT07326020

Last Updated: 2026-01-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

33 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-20

Study Completion Date

2026-03-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to compare the immediate effects of joint-oriented manual therapy and soft tissue-oriented manual therapy on dorsiflexion angle, static and dynamic balance, muscle-tendon mechanical properties, and thermal variables in physically active individuals with flexible pes planus. The research will be conducted between November 2025 and January 2026 at Hacettepe University, Faculty of Physical Therapy and Rehabilitation. Individuals aged 18-35 years with a Tegner Activity Score between 4 and 6 will be included. Participants will be allocated into three groups: soft tissue-oriented manual therapy group, joint-oriented manual therapy group, and healthy control group. Following randomization, the respective intervention will be applied to the intervention groups, while no intervention will be administered to the control group. Assessments will include the dorsiflexion range of motion (weight-bearing lunge test), myotonometric measurements (Myoton-Pro), static balance (Kinvent force platform), dynamic balance (Y-balance test), and thermographic imaging (FLIR E52). The outcomes of this study are expected to contribute to understanding the immediate effectiveness of manual therapy approaches applied in asymptomatic pes planus and to identify the method providing optimal benefit. Furthermore, the differences observed between individuals with pes planus and healthy controls will serve as a guide for clinical assessments of pes planus.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pes Planus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control

healthy control group without intervention

Group Type NO_INTERVENTION

No interventions assigned to this group

joint mobilization group

subtalar and midtarsal joint mobilization in patients with flexible pes planus

Group Type EXPERIMENTAL

joint mobilization

Intervention Type OTHER

subtalar and midtarsal joint mobilization

myofascial release group

calf and plantar fascia release in patients with flexible pes planus

Group Type EXPERIMENTAL

myofascial release

Intervention Type OTHER

calf and plantar fascia release

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

joint mobilization

subtalar and midtarsal joint mobilization

Intervention Type OTHER

myofascial release

calf and plantar fascia release

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Navicular Drop Test ≥ 10 mm
* Foot Posture Index (FPI) \> 6
* Tegner Activity Scale score between 4 and 6 (inclusive)
* Age between 18 and 35 years


* Age between 18 and 35 years
* Navicular Drop Test \< 10 mm
* Foot Posture Index (FPI) between 0 and 6 (inclusive)
* Tegner Activity Scale score between 4 and 6 (inclusive)

Exclusion Criteria

* Diagnosis of posterior tibial tendinopathy by an orthopedic surgeon
* Presence of plantar fasciitis or moderate/severe hallux valgus
* History of lower extremity surgery or trauma
* Presence of neurological, metabolic, or other musculoskeletal disorders that may affect gait or balance performance
* Receipt of any treatment for pes planus within the past year
* Body mass index (BMI) greater than 30 kg/m²
* Regular participation in sports activities


* Presence of plantar fasciitis or moderate/severe hallux valgus
* Presence of pes cavus deformity
* History of lower extremity surgery or trauma
* Presence of neurological, metabolic, or other musculoskeletal disorders that may affect gait or balance performance
* Body mass index (BMI) greater than 30 kg/m²
* Participation in professional-level sports activities
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hande Guney Deniz

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hande Guney Deniz

Prof. Dr.

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hande Guney-Deniz, Prof. Dr

Role: STUDY_DIRECTOR

Hacettepe University, Faculty of Physical Therapy and Rehabilitation, Departmen of Musculoskeletal Physiotherapy and Rehabilitation, Ankara, Türkiye

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hacettepe University

Ankara, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ozlem Ulger, Dean, Prof. Dr,

Role: primary

+90-312-305 15 76

Bensu Sogut Kazan, MSc.

Role: backup

+90546-663-1719

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

pesplanus2025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.